Indeed, genetic variants in genes involved in energy balance, such as adiponutrin/patatin-like phospholipase domain-containing 3 (PNPLA3) and apolipoprotein C3 (APOC3), or in genes involved in inflammation, oxidative stress and fibrogenesis, such as SOD2, have been demonstrated to be associated with NAFLD and the severity of liver damage [6]–[8]. Here, APOC3 is linked to metabolic dysfunction-associated steatotic liver disease.